HP Inc. v. Berkheimer: Will SCOTUS Finally Clarify Patentable Subject Matter?

It’s a case with a humble beginning, just three Red Line stops south of Loyola’s Corboy Law Center, in the United States District Court for the Northern District of Illinois. But this case also has the potential to effect major and much needed change in the realm of patent law. The Honorable John Z. Lee heard HP Inc. v. Berkheimer in 2016, and subsequently, the case worked its way through the appellate courts. The Supreme Court hasn’t yet decided if it will hear the case because for the last eleven months the Petition for Writ of Certiorari for Berkheimer was pending a submission of an amicus brief from the Solicitor General. The brief—which recommended that the Court deny the Berkheimer petition unless another case, Athena v. Mayo, is granted certiorari—was filed with the Court last week. This case could be one of the first patent subject matter eligibility cases to be heard by the Supreme Court in over five years—despite over 40 rejected petitions on the same issue. Subject matter eligibility matters to inventors, investors, and other patent stakeholders, because it directly impacts what does and does not receive a patent, and thus who does or doesn’t have the right to exclusively market and sell their invention as a reward for their creativity and ingenuity. However, the current test for patent subject matter eligibility, introduced in 2014, has been very difficult for the lower courts to administer. If the Supreme Court decides to grant certiorari for Berkheimer, it will have an opportunity to clarify the test. By more explicitly defining what can and cannot be patented, the Supreme Court, in theory, might better align the expectations of patent examiners, judges, and inventors, allowing the patent system to function more efficiently.

Continue reading “HP Inc. v. Berkheimer: Will SCOTUS Finally Clarify Patentable Subject Matter?”

Intro to IP Through IP Speed Mentoring

At the end of my first semester of law school at Loyola University Chicago School of Law, I was sitting in Professor Cynthia Ho’s office, trying to figure out how to learn more about IP. I’d heard that my chemistry background is a type of a science background beneficial to a patent law career, but did not yet know what that involved. Professor Ho suggested that I attend the next IP speed mentoring event that Loyola was hosting. At that moment, I was thinking “What exactly is speed mentoring?”, “All those strangers!” and “What will I say?”

Continue reading “Intro to IP Through IP Speed Mentoring”

THE Ohio State University and THAT Trademark Application

I will never forget the first time I heard it. It was in an information session hosted by my high school’s college counseling department. The college counselor was talking about finding the “right school for you” by evaluating criteria like school size and location. He suggested, for example, if we liked the big, midwestern feeling of the University of Michigan campus, that we also consider visiting the University of Iowa or Ohio State University. And then it happened. He stopped, and with a wry smile said, “oh I’m sorry, THE Ohio State University.” I didn’t end up attending OSU, as I chose the University of Wisconsin instead, but that memory resurfaced this summer after it was announced that OSU had decided to attempt to trademark the word “the.”

Continue reading “THE Ohio State University and THAT Trademark Application”

Tolls on Trolls: Can State Laws Stop Patent Trolls?

Trolls are bad. They are bad characters in folk tales. There are also bad internet and social media trolls. Patent trolls join this club. But, what exactly are patent trolls and why have they attracted the attention of the Electronic Frontier Foundation and NPR shows such as This American Life, as well All Tech Considered? That’s what I’m here to tell you about – as well as how to possibly stop/limit patent trolls.

Continue reading “Tolls on Trolls: Can State Laws Stop Patent Trolls?”

An Evolving View on Access to Affordable Medicine

Rising drug prices have led to major issues with providing broad access to medicine around the world. While these issues receive significant media attention, it is important to understand fully why these problems exist in order to come up with real solutions. My perspective is shaped in large part by my background as a scientist. As a researcher, I viewed the issue purely through a scientific lens. I was focused on how to improve the drug development process through the technologies we were creating. However, I realized that there were also legal issues constraining technology development that spurred my interest in attending law school to pursue a career in patent law. As a first-year law student, my perspective has already broadened. I now know about legal barriers that can inhibit the impact of those technologies on global access to improved and cheaper medicine.

Continue reading “An Evolving View on Access to Affordable Medicine”

You Want Me to What? Realities of Being an “IP” Law Clerk

Continue reading “You Want Me to What? Realities of Being an “IP” Law Clerk”